Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Klosterfrau Allergin Globuli
- Development stage
- Phase 3
- Lead developer
- MCM Klosterfrau
- Administration
- Oral
01
Overview
Klosterfrau Allergin Globuli is a homeopathic medicinal product developed by MCM Klosterfrau Vertriebs GmbH for the treatment of hay fever and pollen-induced allergic rhinitis. The active ingredient is a D2 dilution of *Adhatoda vasica* (Indian lungwort), which contains the alkaloid vasicin. This component is traditionally thought to dilate bronchial branches and reduce mucus production. The product is formulated as oral sucrose pellets (globuli) and is suitable for children from 6 years of age. It has been evaluated in Phase 3 clinical trials to assess its efficacy and tolerability in pediatric populations suffering from seasonal allergic symptoms such as itchy eyes and sneezing.
- Brand names
- Klosterfrau Allergin Globuliallergin
- Other names
- Adhatoda vasica Dil. D2Adhatoda vasica D2
Beyond the preview
Go deeper on Klosterfrau Allergin Globuli.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Klosterfrau Allergin Globuli.